Donggu Biopharmaceutical(10,350 0.00%)Announced on the 5th that it would expand its investment business in earnest.
At the regular shareholders’ meeting held on the 25th, the company added investment projects related to the establishment and operation management of subsidiaries, such as new technology business financing companies for venture investment, to the purpose of new business.
Donggu Biopharmaceutical has been steadily investing in bio-venture companies in recent years. At the beginning of last year, an investment management office was established. As it has received positive reviews from the market for its bio-venture investment, it plans to continue its successful move this year.
In 2019, it invested 3 billion won in BioNote, a diagnostic reagent company, through an investment association. It is an affiliate of SD Biosensor. SD Biosensor and BioNote are aiming to be listed in the first half and third quarter of this year, respectively. The company expects the corporate value of BioNote to be about 1.7 trillion won.
Nova Cell Technology, the largest shareholder of Dong-gu Biopharmaceutical, recently entered a clinical trial for atopic dermatitis treatment with the goal of listing on the KOSDAQ market in 2021. It recently attracted 13 billion won worth of pre-listing investment (Pre-IPO). It plans to enter the KOSDAQ after passing the technical evaluation within this year.
D&D Pharmatech passed the technology evaluation in July. Although the listing preliminary trial was not approved at the beginning of the year, it chose to reconsider the claim rather than withdraw it. It is planning to be listed within this year.
Donggu Biopharmaceutical is a strategy to invest in bio-ventures with potential as part of discovering future growth industries. In addition to the capital return from investment results, the company plans to open various possibilities such as joint research and product development, business alliances, and prepare food for the future.
Reporter Park In-hyuk [email protected]
Ⓒ Hankyung.com prohibits unauthorized reproduction and redistribution